Jennifer Y. Xie

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Associate Professor

Arkansas State University

Also affiliated: Fundación Juan March (2015); Northwell Health (2024); Apple (Israel) (2016–2018); University of Arizona (2005–2020); The King's College (2015); University of New England (2015); Alabama College of Osteopathic Medicine (2019); Christie's (2015); Arizona Science Center (2014); New York Institute of Technology (2018–2024); Arkansas Biosciences Institute (2020–2023)

Faculty Researcher

29 h-index 58 pubs 3,114 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

Jennifer Y. Xie's research investigates mechanisms underlying pain and neurological disorders, with a focus on utilizing animal models and exploring potential therapeutic targets. Her work has explored the role of microglial inflammation in the development of opioid analgesic tolerance and examined nicotinic acetylcholine receptors as targets for managing neuropathic pain associated with diabetic peripheral neuropathy. She has also investigated the potential mechanisms of osteopathic manipulative treatment for alleviating pain in animal models and explored the use of nanocellulose and gold nanorods to influence neural stem cell differentiation for potential applications in tissue regeneration.

Xie holds a high-impact researcher designation and has an h-index of 29 with over 3,000 citations. She has served as PI on an NSF-funded award totaling $719,800 for the acquisition of an UHPLC-TQ and DESI system to support interdisciplinary ecotoxicological and analytical research at Arkansas State University. Her collaborations include researchers from Arkansas State University, such as Krishna Deo Sharma, Guo-Lei Zhou, and Regina K. Fleming, with whom she has co-authored multiple publications.

Metrics

h-index: 29
Publications: 58
Citations: 3,114

Selected Publications

Potential mechanisms for osteopathic manipulative treatment to alleviate migraine-like pain in female rats (2024)

Frontiers in Pain Research 3 citations DOI OpenAlex
Meta-epidemiologic review: Blinding and sham treatment in clinical trial design for osteopathic manipulative treatment research (2023)

International journal of osteopathic medicine 4 citations DOI OpenAlex
Microglial inflammation modulates opioid analgesic tolerance (2023)

Journal of Neuroscience Research 20 citations DOI OpenAlex
CAP1 (cyclase-associated protein 1) mediates the cyclic AMP signals that activate Rap1 in stimulating matrix adhesion of colon cancer cells (2023)

Cellular Signalling 15 citations DOI OpenAlex
Letters to the editor: Nicotinic acetylcholine receptor ligands as potential targets for managing neuropathic pain induced by diabetic peripheral neuropathy (2022)

eNeurologicalSci 4 citations DOI OpenAlex
Gold Nanorod Substrate for Rat Fetal Neural Stem Cell Differentiation into Oligodendrocytes (2022)

Nanomaterials 7 citations DOI OpenAlex
Functionalized Nanocellulose Drives Neural Stem Cells toward Neuronal Differentiation (2021)

Journal of Functional Biomaterials 8 citations DOI OpenAlex
Chronicling changes in the somatosensory neurons after peripheral nerve injury (2020)

Proceedings of the National Academy of Sciences 13 citations DOI OpenAlex
Predominant differentiation of rat fetal neural stem cells into functional oligodendrocytes in vitro (2020)

Neuroscience Letters 8 citations DOI OpenAlex
Glioma-derived exosomes drive the differentiation of neural stem cells to astrocytes (2020)

PLoS ONE 30 citations DOI OpenAlex
Antihyperalgesic effects of Meteorin in the rat chronic constriction injury model: a replication study (2019)

Pain 21 citations DOI OpenAlex
Inhibition of experimental visceral pain in rodents by cebranopadol (2018)

Behavioural Pharmacology 9 citations DOI OpenAlex